Imax Corporation (IMAX) Stock Price & How to Invest

Last updated November 2026

Short answer

You can invest in IMAX Corporation (NYSE: IMAX) by buying shares or fractional shares at any major broker, through a media or entertainment ETF that holds it, or as one holding in a thematic basket. IMAX is a premium-cinema technology and content company that licenses its large-format projection systems to theaters worldwide and takes a cut of the box office on films shown in the IMAX format. As of 20 November 2026 the stock closed at $46.79, up about 30% in 2026, for a market value near $2.6 billion. The investment picture centers on a record global box office, a growing local-language film slate, and system installations, weighed against reliance on the Hollywood release calendar, a soft Greater China market, and the challenge of following a record 2026 with a 2027 in which analysts expect earnings to fall.

IMAX stock price

As of 2026-11-20, Imax Corporation (IMAX) last closed at $46.13, up 28.0% over the past year. Over the past 52 weeks it has traded between $33.09 and $56.33.

IMAX last close
$46.13
1 day
-0.11%
1 month
-13.11%
1 year
+28.00%
52-week range
$33.09 to $56.33
Last close
2026-11-20

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Imax Corporation's investor relations page. Walnut is informational, not investment advice.

IMAX key stats

At $46.13 on November 20, 2026, Imax Corporation (IMAX) has a market cap of $2.5B and a P/E of 19.5 on trailing earnings (20.3 on forward earnings).

Market cap
$2.5B
P/E (trailing)
19.5
P/E (forward)
20.3
EPS (trailing 12 months)
$2.36
Price to book
5.2
Beta
0.51

Market cap, P/E and yield are measured at the $46.13 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Imax Corporation (IMAX)?

The last two weeks for Imax Corporation, as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • IMAX closed at $46.13 on November 20, 2026, down 4.5% over the past five trading days (from $48.29).
  • On November 18, 2026, Imax Corporation filed an 8-K with the SEC reporting a change in its directors or officers (Item 5.02). Read the 8-K on sec.gov

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Imax Corporation (IMAX) latest quarter

IMAX Corporation reported revenue of $175 million for Q3 2026, up 64% from a year earlier (IMAX Corporation, Nov 5, 2026).

Revenue
$175 million
up 64% from a year earlier
Diluted EPS (GAAP)
$1.96
up 430% from a year earlier
Content Solutions
$94.0 million
up 110% from a year earlier

Source: IMAX Q3 2026 results, Nov 5, 2026. Full earnings breakdown

What does Imax Corporation (IMAX) do?

IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format. Rather than owning most theaters itself, IMAX runs an asset-light model: it sells or leases its projection and sound systems to exhibitor partners, then earns ongoing revenue tied to ticket sales through revenue-share and joint-venture arrangements. Its two reporting segments are Technology Products and Services (the systems, maintenance, and network operations) and Content Solutions (film remastering, distribution, and the growing slate of local-language titles). By 2025 the IMAX network spanned more than 1,700 theaters globally, larger than rival premium formats.

The investment picture rests on premium cinema outperforming the broader box office as audiences pay up for a differentiated experience. In full-year 2025 IMAX reported best-ever revenue of about $410 million, up 16%, alongside a record global IMAX box office of roughly $1.28 billion and record cash from operations near $127 million. Growth drivers include an expanding local-language film slate (led by titles from China, Japan, and India), record system installations and signings, and margin expansion in Content Solutions. In 2026 the results have tracked the film slate quarter by quarter: revenue was about $81 million in a China-hit first quarter and about $103 million in the second, when adjusted EPS of $0.43 beat the $0.27 consensus. The third quarter carried Christopher Nolan's The Odyssey, shot for IMAX, and it was the strongest quarter in the company's history: revenue of about $174.6 million (up about 64% and about 7% above consensus), adjusted EPS of $2.21 against $1.02 expected, and adjusted EBITDA of about $115 million, a 66% margin. GAAP net income for the quarter was about $114 million. The shares edged down about 1.5% to $48.10 after the report. In November 2026 IMAX named Meta's VR glasses the first IMAX certified VR device, signed Showcase Cinemas for 13 new IMAX with Laser locations in the UK and Europe, promoted Giovanni Dolci to chief operating officer, and reported that Godzilla Minus Zero had the biggest global opening for a Japanese film in IMAX history. Offsetting these are the company's dependence on a strong Hollywood release calendar, a volatile Greater China market that dropped sharply in early 2026, rising competition from other premium formats, and a hard comparison in 2027: consensus calls for EPS of about $2.27 next year against about $3.41 in 2026.

What's driving Imax Corporation (IMAX)?

1. Record box office and premium share.

IMAX posted its highest-grossing year ever in 2025 with about $1.28 billion in global box office, up 40% year over year, and indexed roughly a 15% share of premium film releases on opening weekends. Its 2026 guidance calls for approximately $1.4 billion in global box office, which would set another record. Because IMAX earns a revenue share on tickets, box-office strength flows directly to its top line. Wedbush projected in October 2026 that third quarter IMAX box office could reach roughly $712 million on the back of The Odyssey, and the quarter's revenue of about $174.6 million, up about 64% year over year, shows how much of that flowed through. Wedbush also noted that Disney has booked all of its major 2027 titles on the IMAX calendar.

2. Local-language content expansion.

IMAX's local-language box office reached about $405 million in 2025, some 66% above the prior record, as films from China, Japan, and India traveled further than before. The company expects to grow its local-language slate to around 75 titles in 2026 from 67 in 2025. This diversifies IMAX away from sole reliance on the Hollywood tentpole calendar and opens content supply in more markets. Godzilla Minus Zero, released in November 2026, posted the biggest global opening for a Japanese film in IMAX history, according to the company, a sign of how far the local-language slate now travels.

3. Network growth: installations and signings.

IMAX installed 160 systems in 2025 at the high end of guidance and signed 166 new systems, up 28% from 2024, and guides to 160 to 175 installations in 2026. It is pushing an Asia-Pacific expansion strategy across India, Japan, Australia, and Southeast Asia. Each new system widens the network that generates recurring, box-office-linked revenue. In November 2026 IMAX and Showcase Cinemas agreed on 13 new IMAX with Laser locations across the UK and Europe.

4. Margins and cash generation.

Content Solutions margin expanded from 53% in 2024 to 66% in 2025, and the company reported a record adjusted EBITDA margin near 45% with cash from operating activities up 79% to about $127 million. The asset-light licensing model means incremental box-office dollars carry high margins, and the third quarter of 2026 showed it: adjusted EBITDA of about $115 million was a 66% margin, against a $93 million consensus. On a trailing twelve month basis to September 2026, IMAX reported gross margin near 64%, operating margin near 31%, net margin near 28% and free cash flow of about $126 million.

5. New screens beyond the cinema.

In November 2026 IMAX and Meta Platforms announced that Meta's VR glasses would be the first IMAX certified VR device, bringing the IMAX format to a headset. It is an early, small step next to theatrical revenue, but it extends the brand's licensing model to a device category. The same month IMAX promoted Giovanni Dolci to chief operating officer and named Mark Welton president of strategic partnerships.

What are the risks to Imax Corporation (IMAX)?

IMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. Greater China is a swing market: IMAX box office there plunged roughly 62% in the first quarter of 2026 against a very strong prior-year period, showing how concentrated and volatile that geography can be. Competition from Dolby Cinema, Cinemark XD, Regal RPX, ScreenX, 4DX, and exhibitors' own premium-format brands is intensifying, and some operators resent the revenue cut IMAX takes. Longer term, the shift toward streaming and shorter theatrical windows could erode moviegoing. The nearer risk is the comparison: consensus has 2026 EPS of about $3.41 falling to about $2.27 in 2027 on revenue of about $501 million, barely above 2026's expected $489 million, and the December 2026 quarter is expected to show EPS of about $0.57 on revenue roughly 1% lower than a year earlier. A year without an Odyssey-sized release makes those comparisons harder, and the stock fell about 12% in the month to 20 November 2026 despite the third quarter beat.

What is the Imax Corporation (IMAX) forecast?

12 analysts publish price targets on IMAX, averaging $60.00 as of November 2026, or +30.1% against the $46.13 share price on November 20, 2026. The published targets run from $49.00 to $65.00, a narrow spread, and the ratings split 10 buy, 2 hold, 0 sell. Over the last six months there have been 9 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full IMAX forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is IMAX a buy or a sell?

We give no verdict on Imax Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Record box office and premium share. IMAX posted its highest-grossing year ever in 2025 with about $1.28 billion in global box office, up 40% year over year, and indexed roughly a 15% share of premium film releases on opening weekends. The most optimistic published target, $65.00, assumes this works close to its best case.

The case against. IMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. The most pessimistic target, $49.00, is roughly what IMAX is worth if this bites instead.

Read the full bull and bear case on IMAX, including what would have to change to break either one. Walnut is not an investment adviser.

Has Imax Corporation (IMAX) split its stock?

No. Imax Corporation (IMAX) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Imax Corporation (IMAX) valued?

Market cap, P/E and dividend yield at today's price are in the IMAX key stats above. The business figures below come from Imax Corporation's reported results as of November 2026 and change when it next reports.

  • Revenue (TTM to September 2026): ~$484 million; Q3 2026 revenue ~$174.6 million, up ~64% year over year and ~7% above consensus
  • Margins (TTM): Gross ~64%, operating ~31%, net ~28%; Q3 2026 adjusted EBITDA margin ~66%
  • Consensus: 2026 EPS ~$3.41 on revenue ~$489 million; 2027 EPS ~$2.27 on revenue ~$501 million
  • Global IMAX box office: ~$1.28 billion in 2025 (record); 2026 guidance ~$1.4 billion
  • Dividend: None

As of November 2026: The record third quarter collapsed the gap between trailing and forward P/E that defined the debate in October (about 72 versus 24): both now sit near 20 to 21 times, because trailing earnings caught up while 2027 estimates point lower. The shares are up about 30% year to date and 32% over a year but about 12% below their mid-October level, and the 12 analysts tracked by Yahoo Finance carry a buy consensus with a mean target of $60, about 28% above the 20 November close.

Who competes with Imax Corporation (IMAX)?

Premium large-format cinema formats

Dolby Cinema (over 275 locations, with an exclusive US deal at AMC), Cinemark XD, and Regal Premium Experience (RPX) compete directly for premium moviegoers and the studio relationships that decide which films get a premium release. IMAX's larger network of more than 1,700 theaters is its scale advantage, but these rivals let exhibitors avoid paying IMAX's revenue cut.

Specialty and immersive formats

CJ 4DPLEX's ScreenX (multi-wall projection) and 4DX (motion seats and effects), plus exhibitors' in-house brands like Vue's VueXtreme and Odeon's iSense, offer differentiated premium experiences. They fragment the premium market and give theater chains alternatives to licensing IMAX technology.

Broader competition for viewers

Standard multiplex screens and streaming platforms compete for the same entertainment time and spending. Shorter theatrical windows and at-home viewing options are structural pressures on all theatrical formats, including IMAX, even though IMAX positions itself as an event-going experience that streaming cannot replicate.

What stocks are similar to Imax Corporation (IMAX)?

Other names that sit close to IMAX: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Imax Corporation (IMAX)

There are three common ways to get IMAX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so IMAX sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where IMAX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Imax Corporation (IMAX)

IMAX is a niche, asset-light entertainment-technology company whose results ride the strength of the theatrical film slate and its own network expansion. The summer of The Odyssey delivered the record third quarter analysts expected: revenue of about $175 million, up about 64% year over year, and adjusted EPS of $2.21 against a $1.02 consensus. The shares have still slipped about 12% over the past month, and at about 20 times trailing and 21 times forward earnings the debate has moved from whether 2026 is a record to how far earnings drop in 2027, when consensus EPS falls by about a third.

More on Imax Corporation (IMAX)

Whether IMAX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is IMAX a buy or a sell?, and where the stock could go from here in the IMAX stock forecast.

For income investors, whether IMAX pays a dividend and how the payout looks is covered in does IMAX pay a dividend? And to weigh IMAX against a peer, read the full side-by-side comparisons: IMAX vs DLB and IMAX vs AMC.

Wondering how IMAX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Imax Corporation

Ask Walnut's AI anything about IMAX and see how it fits what you own.

FAQ

What does IMAX Corporation actually do?

+

IMAX designs premium large-format cinema systems and licenses proprietary projection, sound, and film-remastering technology to theater operators worldwide. It runs an asset-light model, earning revenue from selling or leasing systems and from a share of the box office on films shown in the IMAX format.

Is IMAX a real operating company or a speculative stock?

+

IMAX is a long-established, profitable operating company listed on the NYSE. It reported best-ever revenue of about $410 million in full-year 2025 with a net income margin near 11% and a network of more than 1,700 theaters globally, so it is a real business rather than a speculative shell. As of 20 November 2026 it carried a market value near $2.6 billion, and trailing twelve month net income was about $134 million.

How does IMAX make money?

+

IMAX earns money two main ways: selling, leasing, and maintaining its cinema systems (the Technology Products and Services segment) and remastering plus distributing films while taking a share of ticket sales (the Content Solutions segment). Its results scale with both the number of installed systems and how strong the film box office is.

How did IMAX perform in 2025?

+

IMAX posted best-ever revenue of about $410 million, up 16%, alongside a record global IMAX box office near $1.28 billion, record cash from operations around $127 million, 160 system installations, and 166 signings. Content Solutions margin expanded from 53% to 66% year over year.

What are the biggest risks for IMAX?

+

The main risks are dependence on a strong theatrical film slate, a volatile Greater China market that fell sharply in early 2026, growing competition from rival premium formats, the long-term shift toward streaming, and a tough 2027 comparison. After a record third quarter, consensus expects EPS of about $3.41 in 2026 to fall to about $2.27 in 2027, and at about 20 times trailing earnings in November 2026 the stock still assumes the network keeps growing.

Why does China matter so much to IMAX?

+

Greater China is one of IMAX's largest and most volatile markets. In the first quarter of 2026 its China box office plunged roughly 62% against an exceptionally strong prior-year period, because a single quarter can represent close to half of China's annual IMAX box office, showing how concentrated the exposure is.

Who competes with IMAX?

+

IMAX competes with other premium large-format brands like Dolby Cinema, Cinemark XD, and Regal RPX, with immersive formats such as ScreenX and 4DX, and more broadly with standard theaters and streaming platforms that compete for viewers' time and spending.

How can I invest in IMAX?

+

IMAX trades on the NYSE under the ticker IMAX, so you can buy shares or fractional shares through any major brokerage, gain exposure through media or entertainment ETFs that hold it, or include it as one holding in a thematic basket. Walnut is not an investment adviser, and this is descriptive information, not a recommendation to buy or sell.

How did IMAX do in its latest quarter?

+

In the third quarter of 2026, which included The Odyssey, IMAX reported revenue of about $174.6 million, up about 64% year over year and about 7% above the $163.3 million consensus. Adjusted EPS of $2.21 compared with $1.02 expected, adjusted EBITDA was about $115 million (a 66% margin), and GAAP net income was about $114 million. It was the fifth straight quarterly beat. For the December quarter consensus is EPS near $0.57 on revenue of about $131 million.

How has IMAX stock performed in 2026?

+

IMAX closed at $46.79 on 20 November 2026, up about 30% year to date and about 32% over twelve months, within a 52-week range of roughly $33 to $58. Most of the gain came over the summer; the shares are down about 13% over three months and about 12% over the last month, and edged down about 1.5% right after the record third quarter report. Walnut is not an investment adviser, and past performance does not predict future returns.

What do analysts expect from IMAX in 2027?

+

As of 20 November 2026, consensus on Yahoo Finance calls for 2027 revenue of about $501 million, slightly above the roughly $489 million expected for 2026, and EPS of about $2.27, down about a third from the expected 2026 figure of about $3.41. The 12 analysts tracked carry a buy consensus with a mean price target of $60. Estimates change with the film slate, and Walnut is not an investment adviser.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Imax Corporation's investor relations page or your broker before making investment decisions.